Deal Library / Pharma BD Deal Intelligence

Nephrology Deals

The Pharma Closeout tracks 17 deals, $27.7B in disclosed deal value, 13 with a post-close Outcome Score for Nephrology.

Median Critic Score: 80  ·  Median Outcome Score: 59

Best outcome: Horizon Pharma plc / Crealta Holdings LLC (87)  ·  Weakest outcome: Endo Pharmaceuticals Holdings Inc. / HealthTronics, Inc. (17)

All 17 deals